Is Alphabet an Undervalued Growth Stock to Buy?
Alphabet (NASDAQ:GOOGL) is easily one of the most successful companies…
Sell
26
AWH Quote, Financials, Valuation and Earnings
Last price:
$0.73
Seasonality move
:
20.66%
Day range:
$0.72 - $0.77
52-week range:
$0.67 - $5.65
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
1.05x
P/B ratio:
--
Volume:
94K
Avg. volume:
79.3K
1-year change:
-74.09%
Market cap:
$12.5M
Revenue:
$9.2M
EPS (TTM):
-$1.20
Analysts' Opinion
-
Consensus RatingAspira Womens Health has received a consensus rating of --. The company's average rating is a -- based on 0 Buy ratings, 0 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of --, Aspira Womens Health has an estimated upside of 634.61% from its current price of $0.75.
-
Price Target DownsideAccording to analysts, the lowest downside price target is -- representing 100% downside risk from its current price of $0.75.
Fair Value
-
According to the consensus of 0 analysts, Aspira Womens Health has 634.61% upside to fair value with a price target of -- per share.
AWH vs. S&P 500
-
Over the past 5 trading days, Aspira Womens Health has underperformed the S&P 500 by -1.88% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Aspira Womens Health does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Aspira Womens Health has grown year-over-year revenues for 1 quarter straight. In the most recent quarter Aspira Womens Health reported revenues of $2.3M.
Earnings Growth
-
Aspira Womens Health has grown year-over-year earnings for 0 quarters straight. In the most recent quarter Aspira Womens Health reported earnings per share of -$0.23.
Enterprise value:
11.9M
EV / Invested capital:
-12.44x
Price / LTM sales:
1.05x
EV / EBIT:
--
EV / Revenue:
1.33x
PEG ratio (5yr expected):
--
EV / Free cash flow:
-0.82x
Price / Operating cash flow:
--
Enterprise value / EBITDA:
--
Gross Profit (TTM):
$5.2M
Return On Assets:
-240.12%
Net Income Margin (TTM):
-165.07%
Return On Equity:
--
Return On Invested Capital:
-8215.24%
Operating Margin:
-165.88%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2023-09-30 | 2024-09-30 | |
| Income Statement | ||||||
| Revenue | $7.9M | $9.2M | $9M | $2.2M | $2.3M | |
| Gross Profit | $4.1M | $5.3M | $5.2M | $1.3M | $1.4M | |
| Operating Income | -$35M | -$19.8M | -$17M | -$4.1M | -$3.7M | |
| EBITDA | -$34.7M | -$20.3M | -$16.7M | -$4.1M | -$3.5M | |
| Diluted EPS | -$4.61 | -$2.15 | -$1.20 | -$0.48 | -$0.23 | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $20.3M | $47.2M | $23M | $7.6M | $4.1M | |
| Total Assets | $21.3M | $48M | $23.9M | $8.7M | $4.8M | |
| Current Liabilities | $4.6M | $6.4M | $7.3M | $5.2M | $5.5M | |
| Total Liabilities | $6.7M | $9.5M | $12.8M | $9.3M | $7.3M | |
| Total Equity | $14.6M | $38.5M | $11.2M | -$659K | -$2.5M | |
| Total Debt | $2.2M | $3M | $2.8M | $1.7M | $1.6M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2023-09-30 | 2024-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -$31.6M | -$19.5M | -$14.5M | -$3.3M | -$2.9M | |
| Cash From Investing | -$188K | -$86K | -$49K | -- | -$2K | |
| Cash From Financing | $7.5M | $4.2M | $11.4M | $4.2M | $4.1M | |
| Free Cash Flow | -$31.8M | -$19.6M | -$14.6M | -$3.3M | -$2.9M | |
AWH
Sector
Market Cap
$12.5M
$45.6M
Price % of 52-Week High
13.25%
45.55%
Dividend Yield
0%
0%
Shareholder Yield
-20.39%
-0.74%
1-Year Price Total Return
-74.09%
-31.35%
Beta (5-Year)
1.389
0.772
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Technicals
8-day SMA
Sell
Level
$0.75
200-day SMA
Sell
Level
$1.69
Bollinger Bands (100)
Sell
Level
0.76 - 1.02
Chaikin Money Flow
Sell
Level
-60.8M
20-day SMA
Sell
Level
$0.77
Relative Strength Index (RSI14)
Sell
Level
44.55
ADX Line
Sell
Level
13.78
Williams %R
Neutral
Level
-59.5882
50-day SMA
Sell
Level
$0.82
MACD (12, 26)
Sell
Level
-0.02
25-day Aroon Oscillator
Buy
Level
24
On Balance Volume
Neutral
Level
20.4M
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (-121.2989)
Sell
CA Score
(Annual)
Level (-8.7518)
Buy
Beneish M-Score
(Annual)
Level (-2.9188)
Sell
Momentum Score
Level (1)
Sell
Ohlson Score
Level (15.3241)
Buy
Piotroski F Score
(Annual)
Level (4)
Buy
Quality Ratio Score
Level (7)
Sell
Fundamental Score
Level (1)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Aspira Womens Health Inc is engaged in developing and commercializing diagnostic tests for gynecologic diseases. Its products include OvaSuite which is a portfolio of blood tests that applies proprietary algorithms incorporating patient features; OvaWatch intended for use in assessing the risk of ovarian cancer for women with adnexal masses; and Ova1Plus is a portfolio of blood tests, Ova1Plus is a combination of two FDA-cleared tests for women with pelvic masses who are planned for surgery.
Stock Forecast FAQ
In the current month, AWH has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The AWH average analyst price target in the past 3 months is --.
-
Where Will Aspira Womens Health Stock Be In 1 Year?
According to analysts, the consensus estimate is that Aspira Womens Health share price will rise to -- per share over the next 12 months.
-
What Do Analysts Say About Aspira Womens Health?
Analysts are divided on their view about Aspira Womens Health share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Aspira Womens Health is a Sell and believe this share price will drop from its current level to --.
-
What Is Aspira Womens Health's Price Target?
The price target for Aspira Womens Health over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is AWH A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Aspira Womens Health is a --. 0 of 0 analysts rate the stock a -- at this time.
-
How Can I Buy Shares Of AWH?
You can purchase shares of Aspira Womens Health via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, TastyTrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Aspira Womens Health shares.
-
What Is The Aspira Womens Health Share Price Today?
Aspira Womens Health was last trading at $0.73 per share. This represents the most recent stock quote for Aspira Womens Health. Yesterday, Aspira Womens Health closed at $0.75 per share.
-
How To Buy Aspira Womens Health Stock Online?
In order to purchase Aspira Womens Health stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Tesla Going to Buy Uber?
Tesla has always been in the habit of making large,…
NVIDIA vs Broadcom Stock: Which Is Best?
If you want to invest in an AI-leading tech company,…
Stock Ideas
Buy
65
Is AAPL Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 42x
Buy
57
Is NVDA Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 117x
Buy
53
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 37x
Alerts
Buy
52
TSLL alert for Dec 24
Direxion Daily TSLA Bull 2X Shares [TSLL] is up 19.46% over the past day.
Buy
73
PSIX alert for Dec 24
Power Solutions International [PSIX] is up 27.42% over the past day.
Sell
31
SOXL alert for Dec 24
Direxion Daily Semiconductor Bull 3X Shares [SOXL] is up 11.87% over the past day.
